The top U.S. infectious disease expert said AstraZeneca's suspension of final testing of its COVID-19 vaccine candidate shows "one of the safety valves" built into the studies to spot any potential problems.
from Section Page News - Modern Healthcare https://ift.tt/3k2vras
via IFTTT
